CN102462790A - 一种治疗酒精肝的中药组合物 - Google Patents
一种治疗酒精肝的中药组合物 Download PDFInfo
- Publication number
- CN102462790A CN102462790A CN2010105316144A CN201010531614A CN102462790A CN 102462790 A CN102462790 A CN 102462790A CN 2010105316144 A CN2010105316144 A CN 2010105316144A CN 201010531614 A CN201010531614 A CN 201010531614A CN 102462790 A CN102462790 A CN 102462790A
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese medicine
- medicine composition
- alcoholic liver
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 38
- 210000004185 liver Anatomy 0.000 title claims abstract description 25
- 230000001476 alcoholic effect Effects 0.000 title claims abstract description 19
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 7
- 241000756943 Codonopsis Species 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 17
- 210000000952 spleen Anatomy 0.000 abstract description 12
- 206010023126 Jaundice Diseases 0.000 abstract description 8
- 206010047700 Vomiting Diseases 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 210000002784 stomach Anatomy 0.000 abstract description 6
- 230000008673 vomiting Effects 0.000 abstract description 6
- 238000001035 drying Methods 0.000 abstract description 5
- 210000004072 lung Anatomy 0.000 abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 4
- 230000002411 adverse Effects 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 238000010926 purge Methods 0.000 abstract description 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 240000001972 Gardenia jasminoides Species 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 240000004980 Rheum officinale Species 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 201000010099 disease Diseases 0.000 description 14
- 238000011282 treatment Methods 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000019790 abdominal distention Diseases 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 206010024378 leukocytosis Diseases 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000004916 vomit Anatomy 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 208000007082 Alcoholic Fatty Liver Diseases 0.000 description 1
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010016262 Fatty liver alcoholic Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010041519 Spider naevus Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 208000026594 alcoholic fatty liver disease Diseases 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 210000000188 diaphragm Anatomy 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及治疗酒精肝的药物，尤其涉及一种以植物中草药为原料制成的治疗酒精肝的中药组合物。其特征在于，制成有效成分的原料药按下述重量为：柴胡10-20克，茵陈10-20克，黄芩5-15克，山栀5-15克，陈皮8-20克，半夏5-15克，茯苓8-20克，党参8-20克和大黄5-15克。本发明的诸药配伍，相得益彰，具有和解少阳，舒肝和胃，健脾益肺，理气降逆，清湿热，退黄疸，清热燥湿，泻火解毒，降逆止呕等功效，药效的协同作用，可标本兼治，无副作用，对纵酒过度，损伤脾胃，湿浊内生，郁而化热引起的酒精肝有显著疗效。
Description
技术领域
本发明涉及治疗酒精肝的药物，尤其涉及一种以植物中草药为原料制成的治疗酒精肝的中药组合物。
背景技术
酒精肝是由于长期大量饮酒(嗜酒)所致的肝脏损伤性疾病。轻度症状会出现腹胀、乏力、肝区不适、厌食，还有黄疸、肝肿大和压痛、面色灰暗、腹水、浮肿、蜘蛛痣、发热、白细胞增多(主要因此是中性粒细胞增多)类似细菌性感染，少数有脾脏肿大等症状。中重度除上述症状外，有持续低热、腹泻、四肢麻木、手颤等症状，肝功能检查有AST和ALT中度升高、AST/ALT比值接近3等指标。中医认为酒精性肝炎属中医黄疸、胁痛、呕吐、积聚等范畴，其病因病机为纵酒过度，损伤脾胃，湿浊内生，郁而化热，熏蒸肝胆，胆汁不循常道，浸淫肌肤而发黄。目前治疗酒精肝的药物很多，如西药和静脉注射等，众所周知，西药有副作用，长期用药，带来的结果往往是身体机能退化和药物抵抗，会使身体产生不良反应，还能对药物形成依赖性。医学临床研究表明，中药通过解酒，舒肝，促进血液循环，化痰，可有效改善酒精导致肝脏脂肪病变。因此，本发明特进一步优选采用了一种治疗酒精肝的中药组合物。
发明内容
本发明内容的目的就是针对现有治疗酒精肝病症技术的不足，提供了一种治疗酒精肝的中药组合物，可标本兼治，无副作用，价格低廉，组方简单，易于操作。
本发明解决其技术问题所采用的技术方案是：一种治疗酒精肝的中药组合物，其特征在于，制成有效成分的原料药按下述重量为：柴胡10-20克，茵陈10-20克，黄芩5-15克，山栀5-15克，陈皮8-20克，半夏5-15克，茯苓8-20克，党参8-20克和大黄5-15克。
用法：水煎服，一天一剂，可分两次服用，对服中药困难的患者可少量多次的分服，6付为一个疗程。
本发明进一步的技术方案是：一种治疗酒精肝的中药组合物，其特征在于，制成有效成分的原料药按下述重量为：柴胡15克，茵陈15克，黄芩10克，山栀10克，陈皮12克，半夏10克，茯苓12克，党参12克和大黄10克。
药理作用
柴胡：具有和解少阳，舒肝和胃，升阳举陷的功效，治寒热往来，胸满胁痛，热入血室等症。
茵陈：具有清湿热，退黄疸的功效，用于黄疸尿少，湿疮瘙痒，传染性黄疸型肝炎等症。
黄芩：具有清热燥湿，泻火解毒，止血的功效，用于湿温，暑温胸闷呕恶，湿热痞满，泻痢，黄疸，肺热咳嗽等症。
山栀：具有泻火除烦，清热利湿，凉血解毒等功效，主治热病心烦，肝火目赤，湿热黄疳，疮疡肿毒等症。
陈皮：具有理气降逆，调中开胃，燥湿化痰之功效，主治脾胃气滞湿阻，胸膈满闷，脘腹胀痛，不思饮食，呕吐秽逆，二便不利，肺气阻滞，咳嗽痰多等症。
半夏：具有燥湿化痰，降逆止呕，消痞散结等功效，主治咳喘痰多，呕吐反胃，胸脘痞满，头痛眩晕，痈疽肿毒等症。
茯苓：具有渗湿利水，健脾和胃，宁心安神的功效，可治小便不利，水肿胀满，痰饮咳逆，呕逆，健忘等症。
党参：具有补中益气，健脾益肺等功效，用于脾肺虚弱，气短心悸，食少便溏，虚喘咳嗽，内热消渴等症。
大黄：具有泻下攻积，清热泻火，凉血解毒，逐瘀通经等功效，用于热毒疮疡，暴赤眼痛等症。
本发明的诸药配伍，相得益彰，具有和解少阳，舒肝和胃，健脾益肺，理气降逆，清湿热，退黄疸，清热燥湿，泻火解毒，降逆止呕等功效，药效的协同作用，可标本兼治，无副作用，对纵酒过度，损伤脾胃，湿浊内生，郁而化热引起的酒精肝有显著疗效。病例如下：
周某某，男，32岁，2008年，因形体肥胖，疲乏无力、腹胀、肝区疼痛一周，入院后诊断为，酒精性脂肪肝。检查血脂，血清总胆固醇，甘油三脂，肝功能，总胆红素B超，最终结果医生告知，患者肝脏增大，于是给予药物疗法，口服治疗酒精肝的中药组合物1个月后，肝区痛疼消失，体重减轻，查肝功能恢复正常，又巩固治疗一个月，现已痊愈。
张某，男，49岁，2009年，因觉腹胀，下肢浮肿，乏力，遂至当地医院就诊，诊断为长期酗酒导致肝硬化、腹水，住院治疗采用输白蛋白，口服利尿及保肝药物等方法治疗，疗效欠佳。后改服治疗酒精肝的中药组合物1个月后，自我感觉症状减轻，腹胀，下肢浮肿症状消失，查肝功能，病情基本上痊愈。复查B超：肝胆脾未见异常，又巩固治疗一个月，现已痊愈。
具体实施方式
一种治疗酒精肝的中药组合物，其特征在于，制成有效成分的原料药按下述重量为：柴胡15克，茵陈15克，黄芩10克，山栀10克，陈皮12克，半夏10克，茯苓12克，党参12克和大黄10克。先将药物用水洗净，再用冷水浸泡20-30分钟，使药物完全被水浸透，便于有效成分的溶解，然后将药物放在砂锅、陶瓷或者瓦罐之类的器皿里(不可以用铁锅和铝锅)，加上为药物5-10倍的水，或者比药面高出2-3厘米左右。煎第一遍时，用大火加热到100℃左右时，改用小火加热20分钟就好，将药汤倒在器皿里，再煎第二遍，煎第二遍的方法同第一遍一样，只是时间可以稍微短一些。煎完以后，把这两次煎出的药汤混合在一起服用，总量在300-500毫升，这样可以使药物之间充分作用，有效成分溶出彻底，增强疗效。
Claims (2)
1.一种治疗酒精肝的中药组合物，其特征在于，制成有效成分的原料药按下述重量为：柴胡10-20克，茵陈10-20克，黄芩5-15克，山栀5-15克，陈皮8-20克，半夏5-15克，茯苓8-20克，党参8-20克和大黄5-15克。
2.根据权利要求1所述一种治疗酒精肝的中药组合物，其特征在于，制成有效成分的原料药按下述重量为：柴胡15克，茵陈15克，黄芩10克，山栀10克，陈皮12克，半夏10克，茯苓12克，党参12克和大黄10克。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105316144A CN102462790A (zh) | 2010-10-28 | 2010-10-28 | 一种治疗酒精肝的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105316144A CN102462790A (zh) | 2010-10-28 | 2010-10-28 | 一种治疗酒精肝的中药组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102462790A true CN102462790A (zh) | 2012-05-23 |
Family
ID=46067098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105316144A Pending CN102462790A (zh) | 2010-10-28 | 2010-10-28 | 一种治疗酒精肝的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102462790A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103990006A (zh) * | 2014-06-13 | 2014-08-20 | 李雪梅 | 一种治疗酒精肝的中药组合物 |
-
2010
- 2010-10-28 CN CN2010105316144A patent/CN102462790A/zh active Pending
Non-Patent Citations (1)
| Title |
|---|
| 王秀芝: "脂肪肝诊治新进展", 《北京中医》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103990006A (zh) * | 2014-06-13 | 2014-08-20 | 李雪梅 | 一种治疗酒精肝的中药组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103301267B (zh) | 一种治疗高血压和/或动脉粥样硬化的中药组合物及应用 | |
| CN101721564A (zh) | 一种治疗带状疱疹的中药 | |
| CN103251758B (zh) | 一种治疗丹毒的中药制剂 | |
| CN102872384B (zh) | 治疗脂溢性小儿湿疹的中药湿巾的制备方法 | |
| CN102327503A (zh) | 治疗外感风寒内伤湿热泄泻的中草药 | |
| CN101940680A (zh) | 治疗急性腹泻的中草药 | |
| CN101897930A (zh) | 治疗痛经病的中草药 | |
| CN101417115B (zh) | 一种治疗急性传染性黄疸型肝炎的中药组合物 | |
| CN102462790A (zh) | 一种治疗酒精肝的中药组合物 | |
| CN106237035A (zh) | 一种利用雅连治疗痤疮的中药配方 | |
| CN105435173A (zh) | 通滞和胃止痛汤 | |
| CN101041052B (zh) | 一种内服治疗雷诺氏症的中药组合物 | |
| CN104740227A (zh) | 治疗小儿泄泻的中药制剂 | |
| CN110193076A (zh) | 一种治疗高血压、高血脂、高血粘的中药组合物及制剂 | |
| CN104189511A (zh) | 一种治疗慢性胆囊炎的中药制剂 | |
| CN101912488A (zh) | 治疗月经过少病症的中草药 | |
| CN103446379A (zh) | 一种治疗青光眼的中药口服汤剂 | |
| CN102626498B (zh) | 治疗慢性胰腺炎的前苓赤金汤 | |
| CN102441079A (zh) | 一种治疗湿热水肿的中药组方 | |
| CN101829229A (zh) | 一种治疗湿热痢疾的药物及其制备方法 | |
| CN105663657A (zh) | 一种可有效治疗阴虚火旺的汤剂药物及其制备方法 | |
| CN101085312A (zh) | 一种治疗甲亢的中药 | |
| CN105381333A (zh) | 一种治疗脾肾阳虚的中药组合物 | |
| CN104587416A (zh) | 一种治疗早期肝硬化的中药组合物 | |
| CN102920986B (zh) | 一种治疗糖尿病的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120523 |